U.S. stock futures were lower this morning, with the Dow futures falling more than 50 points on Wednesday.
Shares of nCino, Inc. NCNO fell sharply in today’s pre-market trading after the company reported weaker-than-expected earnings for its fourth quarter.
The company also said it sees first-quarter total revenues of $138.75 million to $140.75 million and adjusted earnings of 15 cents to 16 cents per share.
nCino shares dipped 31.5% to $19.30 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Jayud Global Logistics Limited JYD shares fell 78.3% to $0.3490 in pre-market trading.
- Waton Financial Limited WTF shares tumbled 28% to $14.30 in pre-market trading after jumping 396% on Tuesday.
- Rapport Therapeutics, Inc. RAPP shares dipped 24.7% to $7.20 in pre-market trading following a 5% decline on Tuesday.
- Newsmax, Inc. NMAX shares fell 21.2% to $183.73 in pre-market trading. Newsmax shares surged 179% on Tuesday on continued IPO launch strength.
- Regencell Bioscience Holdings Limited RGC shares declined 9.6% to $26.21 in pre-market trading after falling 9% on Tuesday.
- Microvast Holdings, Inc. MVST declined 7.7% to $1.43 in pre-market trading. Microvast Holdings shares jumped 32% on Tuesday after the company reported better-than-expected fourth-quarter financial results.
- National CineMedia, Inc. NCMI fell 5.8% to $5.63 in pre-market trading.
- MeridianLink, Inc. MLNK fell 5.7% to $17.70 in pre-market trading.
- Hims & Hers Health, Inc. HIMS dipped 5.2% to $29.45 in pre-market trading. Hims & Hers Health shares gained 5% on Tuesday after the company announced it added Lilly’s Zepbound to its telehealth platform.
- Tesla, Inc. TSLA fell 2.4% to $261.95 in pre-market trading. Tesla’s sales in key European markets continued their downward trend in March, extending losses for a third consecutive month in multiple countries as the electric vehicle maker faces mounting challenges from Chinese competition and backlash against CEO Elon Musk‘s political activities
Now Read This:
Photo via Shutterstock
Momentum97.02
Growth94.86
Quality–
Value12.04
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.